NCT03604276View on ClinicalTrials.gov

Neuroinflammatory Response and Headache Control in Patients After Subarachnoid Hemorrhage

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2026

Conditions
Subarachnoid Hemorrhage, AneurysmalHeadacheSubarachnoid Hemorrhage
Trial Locations (1)

04102

Maine Medical Center, Portland

Sponsors

Lead Sponsor

MaineHealth
All Listed Sponsors
lead

MaineHealth

OTHER

NCT03604276 - Neuroinflammatory Response and Headache Control in Patients After Subarachnoid Hemorrhage | Biotech Hunter | Biotech Hunter